CORT
Corcept Therapeutics Incorporated
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $964M | +16.6% |
| Gross profit | $950M | +16.5% |
| Operating income | $111M | −19.0% |
| Net income | $162M | −1.2% |
| EPS | $1.27 | −0.7% |
| Free cash flow | $195M | −1.2% |